Multiple sclerosis treatment biotech stock TG Therapeutics (TGTX) is Monday's IBD 50 Growth Stocks To Watch selection. The stock is clawing back from a sharp drop earlier this month, and Wall Street is expecting to see explosive earnings growth in upcoming quarters. TG Therapeutics holds the No. 4 spot in the IBD 50 behind Travere Therapeutics (TVTX), Eton Pharmaceuticals (ETON) and…
TGTX Stock Outperforms 95% of Stocks. Here's Why.
TGTX stock is recovering from an earnings sell-off in early August. building a base. The biotech stock is testing a key moving average.
61 words~1 min read
